Qinqin Cheng

Affiliations: 
University of Southern California, Los Angeles, CA, United States 
Google:
"Qinqin Cheng"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Cheng Q, Shi X, Zhang Y. (2020) Reprogramming Exosomes for Immunotherapy. Methods in Molecular Biology (Clifton, N.J.). 2097: 197-209
Shi X, Cheng Q, Hou T, et al. (2019) Genetically Engineered Cell-Derived Nanoparticles for Targeted Breast Cancer Immunotherapy. Molecular Therapy : the Journal of the American Society of Gene Therapy
Xu X, Cheng Q, Ou M, et al. (2019) Pain acceptance in cancer patients with chronic pain in Hunan, China: A qualitative study. International Journal of Nursing Sciences. 6: 385-391
Shi X, Cheng Q, Zhang Y. (2019) Reprogramming Extracellular Vesicles with Engineered Proteins. Methods (San Diego, Calif.)
Zhang XN, Cheng Q, Chen J, et al. (2019) A ribose-functionalized NAD with unexpected high activity and selectivity for protein poly-ADP-ribosylation. Nature Communications. 10: 4196
Zhang XN, Dai Z, Cheng Q, et al. (2019) Chemoenzymatic Preparation of 4'-Thioribose NAD. Current Protocols in Nucleic Acid Chemistry. e83
Xu X, Ou M, Xie C, et al. (2019) Pain Acceptance and Its Associated Factors among Cancer Patients in Mainland China: A Cross-Sectional Study. Pain Research & Management. 2019: 9458683
Cheng Q, Liu X, Li X, et al. (2019) Improving spiritual well-being among cancer patients: implications for clinical care. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
Dai Z, Zhang XN, Nasertorabi F, et al. (2018) Facile chemoenzymatic synthesis of a novel stable mimic of NAD. Chemical Science. 9: 8337-8342
Cheng Q, Shi X, Han M, et al. (2018) Reprogramming Exosomes as Nanoscale Controllers of Cellular Immunity. Journal of the American Chemical Society
See more...